FENNEC PHARMACEUTICALS INC COMMON (FENC) Covered Calls

You can sell covered calls on FENNEC PHARMACEUTICALS INC COMMON to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for FENC (prices last updated Mon 4:16 PM ET):

FENNEC PHARMACEUTICALS INC COMMON (FENC) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
7.40 -0.07 6.50 9.50 108K - 0.1B
Covered Calls For FENNEC PHARMACEUTICALS INC COMMON (FENC)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Nov 16 7.5 0.00 9.50 -21.1% -296.2%
Dec 21 7.5 0.00 9.50 -21.1% -126.3%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product candidate is the Sodium Thiosulfate, which has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was founded in 1996 and is based in Research Triangle Park, North Carolina